Madrigal Pharmaceuticals(GB:0JXI)
$386.73-7.74 (-1.96%)
GB:0JXI
Madrigal Pharmaceuticals ownership
$386.73
At close:-7.74 (-1.96%)
Madrigal Pharmaceuticals (0JXI) Ownership - Who Owns Madrigal Pharmaceuticals?
1 Followers
Madrigal Pharmaceuticals (0JXI) Ownership Overview
- 19.24% Insiders
- 24.21% Mutual Funds
- 12.91% Other Institutional Investors
- 12.78% ETFs
- 30.86% Public Companies and Individual Investors
The ownership structure of Madrigal Pharmaceuticals (GB:0JXI) stock is a mix of institutional, retail, and individual investors. Approximately 49.90% of the company’s stock is owned by Institutional Investors, 19.24% is owned by Insiders, and 30.86% is owned by Public Companies and Individual Investors.
Institutional holdings as of
The ownership structure of Madrigal Pharmaceuticals (GB:0JXI) stock is a mix of institutional, retail, and individual investors. Approximately 49.90% of the company’s stock is owned by Institutional Investors, 19.24% is owned by Insiders, and 30.86% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Nov 05, 2026 | Baker Bros. Advisors Lp | $35,022,684 | |
| Sep 10, 2026 | William John Sibold | $3,407,371 | |
| Aug 19, 2026 | Shannon T Kelley | $341,940 | |
| May 17, 2026 | David Soergel | $435,420 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | $618,445 | |
| Dec 31, 2025 | Bridgewater Associates, Lp | $11,191,410 | |
| Dec 31, 2025 | Gilder Gagnon Howe & Co Llc. | $19,489,755 | |
| Dec 31, 2025 | Driehaus Capital Management Llc | $65,027,578 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Baker Bros. Advisors Lp | 2,244,403 | Insider | 9.66% | 867,977,972 |
| Felix Baker | 2,143,131 | Institution | 9.23% | 828,813,052 |
| John Paulson | 1,491,619 | Institution | 6.42% | 576,853,816 |
| Vanguard Index Funds | 1,468,704 | Institution | 6.32% | 567,991,898 |
| Vanguard | 1,436,628 | Institution | 6.18% | 555,587,146 |
| BlackRock, Inc. | 1,239,063 | Institution | 5.33% | 479,182,834 |
| Rebecca Taub | 1,108,207 | Insider | 4.77% | 428,576,893 |
| Janus Investment Fund | 1,023,473 | Institution | 4.41% | 395,807,713 |
| Paul A. Friedman | 842,704 | Insider | 3.63% | 325,898,918 |
| Ishares | 575,055 | Institution | 2.48% | 222,391,020 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 1,468,704 | Institution | 6.32% | 567,991,898 |
| Janus Investment Fund | 1,023,473 | Institution | 4.41% | 395,807,713 |
| Vanguard Specialized Funds | 563,117 | Institution | 2.42% | 217,774,237 |
| Fidelity Concord Street Trust | 198,002 | Institution | 0.85% | 76,573,313 |
| Columbia Funds Series Trust I | 191,293 | Institution | 0.82% | 73,978,742 |
| Vanguard Explorer Fund | 190,140 | Institution | 0.82% | 73,532,842 |
| Lord Abbett Securities Trust | 144,625 | Institution | 0.62% | 55,930,826 |
| Fidelity Salem Street Trust | 114,814 | Institution | 0.49% | 44,402,018 |
| Fidelity Select Portfolios | 98,095 | Institution | 0.42% | 37,936,279 |
| Manager Directed Portfolios | 86,744 | Institution | 0.37% | 33,546,507 |
FAQ
Who Owns Madrigal Pharmaceuticals (GB:0JXI)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 49.90% of the company's stock is held by institutional investors, 19.24% is held by insiders, and 30.86% is held by public companies and individual investors.
What percentage of Madrigal Pharmaceuticals (GB:0JXI) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 49.90% of Madrigal Pharmaceuticals (GB:0JXI) stock is held by institutional investors: 24.21% by mutual funds, 12.78% by ETFs and 12.91% by other institutional investors.
What percentage of Madrigal Pharmaceuticals (GB:0JXI) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 30.86% of Madrigal Pharmaceuticals (GB:0JXI) stock is held by public companies and individual investors.
Who owns the most shares of Madrigal Pharmaceuticals (GB:0JXI)?
Baker Bros. Advisors Lp owns the most shares of Madrigal Pharmaceuticals (GB:0JXI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

